Australian Clinical Labs Ltd
ASX:ACL
Australian Clinical Labs Ltd
ASX:ACL
Price:
2.52
AUD
0.4%
Market Closed
Market Cap:
AU$490.3m
Balance Sheet
Balance Sheet Decomposition
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Balance Sheet Decomposition is not available for
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Balance Sheet
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Currency: AUD
| Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
7
|
7
|
4
|
35
|
35
|
26
|
20
|
26
|
21
|
|
| Cash Equivalents |
7
|
7
|
4
|
35
|
35
|
26
|
20
|
26
|
21
|
|
| Short-Term Investments |
0
|
3
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Receivables |
41
|
41
|
46
|
63
|
63
|
91
|
75
|
81
|
73
|
|
| Accounts Receivables |
29
|
33
|
45
|
62
|
62
|
87
|
70
|
76
|
70
|
|
| Other Receivables |
11
|
9
|
2
|
1
|
1
|
4
|
5
|
6
|
2
|
|
| Inventory |
8
|
7
|
10
|
10
|
13
|
20
|
15
|
17
|
16
|
|
| Other Current Assets |
3
|
3
|
4
|
3
|
5
|
4
|
5
|
8
|
10
|
|
| Total Current Assets |
58
|
61
|
65
|
112
|
117
|
143
|
116
|
134
|
120
|
|
| PP&E Net |
38
|
34
|
42
|
194
|
238
|
310
|
288
|
282
|
270
|
|
| PP&E Gross |
38
|
34
|
42
|
194
|
238
|
310
|
288
|
282
|
270
|
|
| Accumulated Depreciation |
56
|
61
|
75
|
152
|
237
|
341
|
117
|
130
|
142
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
7
|
7
|
6
|
6
|
6
|
|
| Goodwill |
13
|
13
|
36
|
36
|
106
|
159
|
159
|
159
|
159
|
|
| Long-Term Investments |
0
|
1
|
0
|
1
|
0
|
0
|
1
|
2
|
2
|
|
| Other Long-Term Assets |
12
|
10
|
11
|
23
|
16
|
9
|
8
|
11
|
17
|
|
| Other Assets |
13
|
13
|
36
|
36
|
106
|
159
|
159
|
159
|
159
|
|
| Total Assets |
121
N/A
|
119
-2%
|
154
+29%
|
366
+138%
|
484
+32%
|
628
+30%
|
579
-8%
|
593
+2%
|
575
-3%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
7
|
9
|
12
|
13
|
19
|
26
|
18
|
26
|
21
|
|
| Accrued Liabilities |
30
|
31
|
37
|
37
|
43
|
46
|
44
|
45
|
46
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
63
|
70
|
95
|
101
|
105
|
109
|
|
| Other Current Liabilities |
16
|
16
|
17
|
23
|
34
|
58
|
25
|
32
|
42
|
|
| Total Current Liabilities |
54
|
57
|
66
|
135
|
166
|
225
|
188
|
208
|
216
|
|
| Long-Term Debt |
48
|
52
|
56
|
158
|
234
|
168
|
215
|
204
|
182
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
4
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
5
|
|
| Total Liabilities |
107
N/A
|
114
+6%
|
126
+11%
|
297
+135%
|
402
+35%
|
396
-2%
|
406
+3%
|
416
+2%
|
403
-3%
|
|
| Equity | ||||||||||
| Common Stock |
239
|
239
|
147
|
147
|
798
|
798
|
798
|
798
|
781
|
|
| Retained Earnings |
224
|
233
|
119
|
78
|
716
|
561
|
620
|
614
|
604
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
5
|
6
|
6
|
5
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
14
N/A
|
5
-61%
|
27
+402%
|
69
+152%
|
82
+19%
|
232
+184%
|
172
-26%
|
178
+3%
|
171
-3%
|
|
| Total Liabilities & Equity |
121
N/A
|
119
-2%
|
154
+29%
|
366
+138%
|
484
+32%
|
628
+30%
|
579
-8%
|
593
+2%
|
575
-3%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
202
|
202
|
202
|
202
|
202
|
202
|
201
|
200
|
194
|
|
Switch to:
Switch to:
See Also
Discover More
